U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511543) titled 'Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy' on March 30.
Brief Summary: Endovascular thrombectomy (EVT) is a procedure that improves recovery for people who suffer from a stroke by removing blood clots from large blood vessels in the brain. However, even with this treatment, over half of the patients either pass away or are left with serious disabilities within three months. This is partly because, even in cases of a successful EVT, brain tissue damage continues to grow. Extent of brain damage is a major factor in how well a patient recovers. Studies in animals have shown that a drug called semagl...